Xue Yang

5PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 11, 2024
PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma.

Khaled Mohamed Nassar, Xue Yang, Adriana Baker

|May 24, 2024
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis.

Behnam Ebrahimi, Suryavathi Viswanadhapalli, Uday P Pratap

|Dec 23, 2023
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.

Nicole Spencer, Alondra Lee Rodriguez Sanchez, Rahul Gopalam

|Dec 06, 2023
Effectiveness of TruScreen for detecting CIN2+ in women with ThinPrep cytologic test results indicating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions.

Xue Yang, Ling He, Xiao Xiao

|Jul 26, 2023
Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma.

Uday P Pratap, Michael Tidwell, Henriette U Balinda

Pageof 1

Frequent Collaborators

4 joint publications

Suryavathi Viswanadhapalli

4 joint publications

Ratna K Vadlamudi

3 joint publications

Gangadhara R Sareddy

2 joint publications

Uday P Pratap